Abstract Background: Previous investigation of the relationship between physical performance and patient self-report physical function (PF) measures in intensive care unit (ICU) survivors have not been performed. Objectives: To (1) analyze the extent to which other activitybased measures of physical performance may serve as proxies for the 6-min walk test (6MWT); (2) determine the extent to which the Short Form (SF) 36 domain of PF and physical component summary (PCS) score, reflect components of physical performance and (3) examine the relationship between demographic and ICU variables and the 6MWT. Design: Cross-sectional data from two clinical trials. Setting: Two acute care hospitals (Melbourne, Australia and Denver, USA). Patients: A total of 177 survivors of ICU. Measurements: Were evaluated at 3 months. Performance-based measures were: 6MWT, timed up and go test (TUG), the five times sit to stand test (59STS), the Berg balance scale (BBS) and two self-report measures: the SF-36 PF domain and the PCS score. Main results: 6 MWT showed excellent correlation with the TUG (rho = -0.79) and BBS (rho = 0.80); and good correlation with 59STS (rho = -0.69) and SF-36 PF scores (rho = 0.69). 6MWT explained 54 and 33 % of variance in SF-36 PF and PCS scores respectively. No variables were clinically important in predicting 6MWT. Conclusions: The 6MWT and TUG may both be acceptable measures of PF performance 3 months after ICU. Performance-based tests measure different constructs than selfreport measures and choice of outcome variables should be aligned with study aims to ensure the most appropriate measure is used.
Introduction
The long-term consequences of a critical illness have recently been defined using a model of impairment [1] and reduced physical function (PF) is one of the most common limitations for ICU survivors [2] .
Performance-based measurement of functional ability after ICU discharge has been undertaken using a variety of measures, including the 6-min walk test (6MWT) [3, 4] , shuttle walk test and timed up and go test (TUG) [3] . These tests tap into the domain of 'activities' as defined by the International Classification of Function and Disability and Health (ICF) [5] . Self-report measures (patient-reported outcomes) measure patient perception of their functional ability or level and include the Short Form (SF) 36 [6] and Katz activities of daily living [7] . These measures tap into the domain of 'participation' as defined by the ICF. Embedding assessment measures into the ICF framework may aid choice of the right measures for patients at the correct timing of recovery [5] .
The aim of this paper was to compare outcomes of function using both performance and self-report measures in ICU survivors at 3 months post critical illness. The specific purposes of the study were to (1) analyze the extent to which other (more expedited) activity-based measures of physical performance may serve as proxies for the 6MWT; (2) determine the extent to which the SF-36 domain of PF and physical component summary (PCS) score, measures of physical participation, reflect components of physical performance and (3) examine the relationship between demographic and ICU variables and the 6MWT at 3 months.
Materials and methods

Design and setting
The data in this cross-sectional study are from two randomized controlled trials. One trial, conducted by Denehy and colleagues from Melbourne, Australia is complete and published [3] and the other is ongoing in Denver, Colorado, USA. The data presented are from 3 months post ICU discharge (Australia) and 3 months post ICU admission (USA). Data were censored in the US arm at the date of data download and all consecutive patient data were used until the time of censoring. Ethical approval was obtained for both trials from respective ethical review boards at Austin Health, Melbourne, Australia and Colorado Multiple Institutional Review Board at University of Colorado, Anschutz Medical Campus, Denver, USA. Both trials were registered; Australian New Zealand Clinical Trials Registry (ACTRN): 12605000776606; US registration: Clinical trials.gov: NCT01058421.
Since the US study is ongoing the participant numbers represent a smaller proportion than those in the Australian study. Not all measurements were collected in both studies, although three of five reported are the same (6MWT, TUG and SF-36). Consequently the sample size varies for reported variables.
Participants
For both patient populations, all participants were admitted to an intensive care unit (ICU), were more than 18 years old, English speaking, and did not have a physical or cognitive impairment that would prevent exercise. The Australian trial recruited participants who were in the ICU for 5 days whereas the US trial is recruiting participants who were in the ICU and mechanically ventilated for at least 4 days. Demographic details at trial recruitment and functional and healthrelated quality of life PF domain values at 3 months post critical illness were extracted from the two trial databases by database managers at each site.
Performance-based functional activity measures
Further details of the method of testing in each test are described in the Electronic Supplementary Material (ESM). The 6MWT test was used to measure functional exercise ability [8] . Developed for older adults, the TUG measures functional mobility and assesses the time (in seconds) taken to stand from a chair, walk 3 m and return to the sitting position [9] . The five times sit to stand test (59STS) involves timing the participant to stand up and sit down again five times as quickly as possible with the arms folded across the chest [10] . This test and the following Berg balance scale (BBS) were measured only in the US cohort. The BBS [11] is a 14-item test of balance that was previously validated against the TUG and Barthel index. The maximum score is 56 where a score range of 41-56 = low fall risk, 21-40 = medium fall risk and 0-20 = high fall risk.
Self-report participation measures of function
The SF-36 version 2 (SF-36v2) is an eight-domain, generic health status questionnaire [12] that has been validated [13] and recommended for use in the ICU population [14] . The PF domain and PCS scores are used in this study to compare with performance measures. The questions that make up the PF domain are given in the ESM in Table E1 . The SF-36 was used in all participants and administered face to face in 100 and 98 % of the US and Australian populations respectively at 3 months.
Factors associated with performance-based PF Risk factors that may be associated with PF performance at 3 months were identified from demographic details and ICU variables and included length of stay in ICU, time on mechanical ventilation (MV) and illness severity at ICU admission using the APACHE II score.
Data analyses
A full description of data analyses is available in the ESM. Demographics were calculated and are presented for the total sample as well as the Australian and US samples separately. To analyze correlations between the 6MWT (continuous variable) and the other functional tests (aim 1), the Spearman's rank correlation coefficient was used. To determine the extent to which other measures of physical performance serve as proxies for the 6MWT (aim 2), a general linear model was used to examine how much of the variance in SF-36 PF domain (transformed percentage score) and SF-36 PCS scores (US normed t scores) was explained by 6MWT distances and TUG times. Potential covariates also included in analyses were demographic (age, gender) and ICU-based (APACHE II scores, MV days and ICU LOS) variables. A categorical TUG variable was created on the basis of the frequency distribution (quartiles) of ''completers'' scores which also included a group for the subjects who scored 120 (could not complete) and used in regression analyses. The TUG categories were 1 = 120; 2 = 12.51-84; 3 = 9.01-12.5; 4 = 7.01-9; 5 = 0-7 s. Finally, to examine the relationship between demographic and ICU variables and the performance-based 6MWT at 3 months (aim 3), the 6MWT was (1) dichotomized to above or below 50 % of predicted normal values [3, 15] , and logistic regression was used and (2) continuous values of percentage predicted 6MWT were used in a linear regression model.
Results
A total of 177 patients completed performance-based and self-report measures at 3 months after critical illness. Demographics at ICU discharge for the total sample and US and Australian samples separately are presented in Table 1 . Median (IQR) ICU LOS (days) was 16 (9.8-23.5) for the US compared to 7 (6-11) for the Australian sample. Also, MV days was 11 (8-18) for the US compared to 3.8 (1.1-6.9) in the Australian sample.
Results of the performance-based PF tests are presented in Table 2 . The median (IQR) 6MWT was 394 (274-485) m (25 % of patients walked less than 274 m and 25 % walked more than 485 m). At 3 months, five of 127 participants (4 %) were unable to perform the 6MWT and four (3 %) walked less than 100 m. Two of these five participants were from the Australian sample and both were able to complete the TUG; however, the three US participants were not able to complete the TUG and only one was able to complete the BBS and 59STS test.
The median (IQR) percentage change in 6MWT distance between walks 1 and 2 for the Australian sample was -1.82 (-4.22 to 3.70) m. Floor effects for the 6MWT occurred in 3.9 % of participants. The mean TUG time was 14.96 s; floor effects for the TUG test occurred in 2.3 % of patients. The mean 6MWT was 55 % of predicted values [15] and the mean TUG was 59 % of predicted values [16] . Thirty-five percent (45/127) of participants' 6MWT distance fell below 50 % of predicted values.
Two other variables had substantial floor or ceiling effects for the ICU population at 3 months post ICU admission: The BBS demonstrated a ceiling effect with 12 out of 26 (46 %) subjects scoring 56, the highest score possible. The 59STS demonstrated a floor effect with nine out of 26 (35 %) subjects unable to perform the test. Results of the self-report participation tests are also in Table 2 . The median PF domain score of the SF-36 was 70 %, which was 83 % of predicted and the median PCS norm-based score was 41.7/50 (83 %).
The 6MWT demonstrated excellent correlation with the BBS and TUG (see ESM Fig. E1 6MWT and TUG scatterplot) and good correlation with the 59STS. Table 3 presents the correlations. Participants with higher 6MWT distances tended to score lower (better) on the TUG (ESM Fig. E1 ). The 6MWT demonstrated good correlation with the SF-36 PF and SF-36 PCS. Participants with higher 6MWT distances tended to score higher on the SF-36 PF domain (Fig. 1) . As mean time to complete the TUG decreased (higher level of function), there was a trend for increasing SF-36 PF domain scores (aim 2).
With SF-36 PCS as the dependent variable (ESM Table E2 ), there was no significant association for APACHE II, gender and age. ICU LOS was excluded owing to colinearity with MV days (r = 0.827). With SF-36 PF as the dependent variable, TUG and significant covariates were entered using a stepwise general linear model that included 6MWT. TUG was the only variable that retained a significant association (p = 0.007) with SF-36 PF. The final model is given in Table 4 . This model explains 54.3 % of the variance in the SF-36 PF score. With SF-36 PCS as the dependent variable, 6MWT explained 29.8 % of variance in SF-36 PCS summary scores in this model (Table 4) , with the addition of TUG only increasing this to 33.3 % (aim 2).
Finally, we examined whether any of the ICU or demographic covariates above were able to predict 6MWT distance walked at 3 months (aim 3). Forty-five of 127 subjects (35 %) scored less than 50 % of predicted values. When each covariate was entered separately into a logistic regression model, the only variable that was significant in the model (p = 0.038) was ICU LOS (MV time was not significant on univariate analysis). However this covariate had an odds ratio (95 % CI) of 1.047 (1.002-1.094) and sensitivity of only 13 %. Similarly the linear regression demonstrated that the entered covariates explained 13.8 % of predicted 6MWD (p \ 0.001). However, while ICU LOS made a unique contribution to the percentage predicted 6MWT (b = 0.24) this did not reach significance (p = 0.117).
Discussion
In a population of moderately unwell ICU survivors from a mixed medical/surgical ICU we found that the 6MWT physical component summary score (US normed t score), Berg Berg balance score, 59STS five times sit to stand test and TUG were highly correlated, and 6MWT and SF-36 PF domain correlated moderately. Together, the 6MWT and TUG explained 54 % of the variance in the PF domain score and 33 % of the PCS score of the SF-36v2. No variables tested were clinically significant in predicting the 6MWT distance at 3 months. We additionally report that PF ability was reduced compared with normal values at 3 months after ICU admission/discharge on both performance-based activity tests and patient self-report physical participation tests. The 6MWT measures functional exercise capacity and is reported to most closely reflect activities of daily living [8] . Indeed, the 6MWT was reported as an indicator of overall physical performance and mobility in populations of older people [17] . The TUG was developed in the geriatric population to test functional ability since it includes the components of sit to stand (function) and turning (balance) in addition to walking, yet we found a high correlation between these two performance-based tests. This result is consistent with others where significant correlations between 6MWT distances and measures of mobility, including standing balance, chair stands and gait speed, in 86 older adults are reported [17] , although ours is the only work to date to measure both of these tests concurrently in ICU survivors. Additionally, it is noteworthy that the differences between two consecutive 6MWT in the Australian sample were very small. Although it is recommended that the 6MWT be performed twice [8, 18] , it may be possible at subsequent follow-up that only one test is required in ICU survivors as the practice effect at 3 months post ICU discharge was very small.
The TUG test requires only a small space to perform (10 m) while the 6MWT requires a 30-m corridor. On this basis, given the excellent correlation, it may be possible to use the TUG in place of the 6MWT when the goal is to measure activity limitations. Both tests have normative data published for comparison and both measure activity limitations which result from impairments in strength that likely occurred during the ICU stay [5] . Neither test had large floor or ceiling effects in our sample. TUG is also reported to predict discharge destination in geriatric and hip replacement populations [19] . For these reasons, the TUG shows promise as a measure of activity; however, the responsiveness of the test to interventions needs to be established.
While there were good correlations between the 6MWT and both the BBS and 59STS tests, these tests exhibited large ceiling or floor effects respectively in our population. The reduction in the range of scores on the BBS resulting from half the participants achieving the highest score may have effected the high correlation obtained for this test [20] . The 59STS was too difficult for 35 % of the population, as standing from sitting requires a whole body movement that includes integration of muscle activity, proprioceptive responses and cognitive function [21] .
There was a moderate correlation between 6MWT and SF-36, consistent with other findings in an ICU population [22] . Given that 6MWT is reported to be a submaximal test which is closely related to activities of daily living, this level of association is not surprising. This premise is further supported in that cardiopulmonary exercise testing (CPET), a maximal intensity test, was not correlated with either SF-36 PF or PCS in an ICU population [23, 24] .
Iwashyna and Netzer suggest using a conceptual framework to guide choice of assessments and subsequent interventions after critical illness, anchored in the World Health Organization's (WHO) ICF [5] . Within the model there is recognition that body systems (including impairment), activity limitation, restriction in participation, and quality of life are distinct aspects of response to a given illness. These different aspects may require unique approaches to assessment and treatment. For example, more than one measure may be required to differentiate limitations and participation at different time Although self-report measures capture recovery from the very important perspective of the patient, these are known to be affected by a phenomenon called response shift [26] . This shift refers to the individuals' recalibration or reconceptualization of their expectations related to the underlying construct as a result of their individual experience of ICU and recovery [26] . Furthermore, at 3 months, the support of family, caregivers, patient resilience and psychological impairments all may impact patient perception of activity and participation. This finding is perhaps demonstrated well by examining the findings of Elliott et al. where there was improvement in 6MWT distance greater than the reported minimal important clinical difference (25-35 m) [27, 28] at 6 months but the SF-36 PF domain improved by only one point over the same time frame (5 points is the reported MCID) [4] .
ICU LOS was found to be significant in the dichotomized model, albeit perhaps not clinically relevant, as a predictor of achieving lower or higher distances on the 6MWT at 3 months. This finding was not supported when the 6MWT was used as a continuous variable. Using the 50 % value was decided upon a priori and based on findings that the mean percentage predicted 6MWT in the Australian study [3] was 52 % at 3 months. We felt that it provided a good cut point to examine factors that may impact which patients reached this (arguably low) mean percentage predicted 6MWT. This finding is interesting since the low sensitivity suggests that length of time in ICU, which is reported to reduce muscle strength [29] , only weakly or does not predict 6MWT values at 3 months. There may be several reasons for this finding; Firstly, the type and intensity of physical therapy in the ICU may be variables that affect 6MWT performance after hospital discharge but we did not measure these. Secondly and importantly, other lifestyle factors may intervene between ICU and hospital discharge and the follow-up at 3 months that may impact muscle strength and functional exercise capacity. We previously reported that the number of steps per day achieved in our Australian cohort at 2 months was low compared with expected values [30] . These findings reinforce that survivors are relatively inactive compared with population norms, which may in turn affect their performance-based activity as measured using the 6MWT. Certainly that only 55 % of predicted values were reached by 3 months may be related to activity levels once the patients return home.
Limitations
While combining data from these two studies increases sample size and improves generalizability of findings, the inclusion criteria were slightly different between studies. As nearly half of the patients in the Australian trial were surgical, these individuals may have been more highly functioning premorbidly; this needs to be considered when generalizing results from this work. The data analyses performed for this manuscript involved pooling data from both studies across both arms of the trials. Given that the US patient numbers were small and the Australian trial showed no differences between groups we felt that data pooling was acceptable. Additionally, it is not possible to extrapolate our findings to other points of the patient trajectory since the relationship between patient self-report participation in physical activity and performance-based measures of activity may conceivably change over time during recovery. We acknowledge that for the tests only conducted in the USA, the sample sizes for outcomes are small.
Conclusion and recommendations
TUG and 6MWT were highly correlated at 3 months after critical illness suggesting that either of these two performance measures may be used at this time point. The 6MWT and TUG explained only half or one-third of selfreported PF measured using SF-36 PF domain and PCS summary score respectively. While the 6MWT remains a useful measure of functional exercise capacity, even for quite disabled ICU survivors, it does not provide comprehensive information on the impact of how activity limitation impacts participation. This is important information for individualizing patient treatments. We therefore conclude that performance-based tests measure different constructs than the SF-36 and that both types of measures may be needed at different time points of patient recovery to provide the most useful information at the right time to guide further patient management.
We recommend use of both performance-based and self-report tests integrated in the ICF model, but they should not be used interchangeably, rather, the most appropriate test should be chosen depending on whether activity limitation or restriction of participation is of most interest to the assessor and patient. For example a study with a primary aim focused on physical performance (e.g., muscle and functional recovery) may use the 6MWT or TUG test as primary outcome measure, whereas a study more focused on the patient's ability to re-integrate into their home, work and social environment may use the SF-36 as a primary outcome, rather than 6MWT.
